| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $302,605 ) |
| | 2025 | 2025 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43GM157885 | Synthetic biology approaches for bio-orthogonal labeling of circular RNAs | 000 | 1 | NIH | 1/22/2025 | $302,605 |
| | 2025 | 2022 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43NS129441 | A Novel TDP-43-Targeting Circular RNA to Treat Amyotrophic Lateral Sclerosis (ALS) | 000 | 1 | NIH | 2/10/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $608,668 ) |
| | 2024 | 2024 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43TR004890 | Development of circRNA manufacturing platform in yeast | 000 | 1 | NIH | 12/20/2023 | $297,608 |
| | 2024 | 2024 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R44GM139433 | Next-generation RNA synthesis and labeling kits | 000 | 4 | NIH | 8/28/2024 | $311,060 |
| | 2024 | 2022 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43DK133031 | Circular RNA aptamers to regulate iron homeostasis in iron overload disorders | 000 | 1 | NIH | 7/15/2024 | $0 |
| | 2024 | 2021 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43NS122654 | Circular mimics of Iron-response elements to inhibit ferroptosis | 000 | 1 | NIH | 3/28/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $600,998 ) |
| | 2023 | 2023 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R44GM139433 | Next-generation RNA synthesis and labeling kits | 000 | 3 | NIH | 9/13/2023 | $600,998 |
| | 2023 | 2020 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43HG011214 | Circular RNA as a platform for genome-wide microRNA sponge libraries | 000 | 1 | NIH | 2/17/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,097,412 ) |
| | 2022 | 2022 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43DK133031 | Circular RNA aptamers to regulate iron homeostasis in iron overload disorders | 000 | 1 | NIH | 6/16/2022 | $255,236 |
| | 2022 | 2022 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R44GM139433 | Next-generation RNA synthesis and labeling kits | 000 | 2 | NIH | 8/30/2022 | $586,018 |
| | 2022 | 2022 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43NS129441 | A Novel TDP-43-Targeting Circular RNA to Treat Amyotrophic Lateral Sclerosis (ALS) | 000 | 1 | NIH | 9/7/2022 | $256,158 |
|
| Issue Date FY: 2021 ( Subtotal = $433,356 ) |
| | 2021 | 2021 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43NS122654 | Circular mimics of Iron-response elements to inhibit ferroptosis | 000 | 1 | NIH | 8/27/2021 | $433,356 |
| | 2021 | 2020 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43GM139433 | Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells | 000 | 1 | NIH | 7/19/2021 | $0 |
| | 2021 | 2020 | CHIMERNA THERAPEUTICS, INC. | 3960 BROADWAY | NEW YORK | NY | 10032-1543 | NEW YORK | USA | R43GM139433 | Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells | 001 | 1 | NIH | 8/29/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $450,000 ) |
| | 2020 | 2020 | CHIMERNA THERAPEUTICS INC. | 455 MAIN ST APT 9B | NEW YORK | NY | 10044-0198 | NEW YORK | USA | R43GM139433 | Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells | 000 | 1 | NIH | 7/31/2020 | $225,000 |
| | 2020 | 2020 | CHIMERNA THERAPEUTICS INC. | 455 MAIN ST APT 9B | NEW YORK | NY | 10044-0198 | NEW YORK | USA | R43HG011214 | Circular RNA as a platform for genome-wide microRNA sponge libraries | 000 | 1 | NIH | 8/3/2020 | $225,000 |
|
|
